Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,904.80
+33.80 (1.81%)
Jul 3, 2026, 3:30 PM IST
NSE:SUNPHARMA Revenue
In the fiscal year ending March 31, 2026, Sun Pharmaceutical Industries had annual revenue of 584.62B INR with 11.19% growth. Sun Pharmaceutical Industries had revenue of 146.12B in the quarter ending March 31, 2026, with 12.76% growth.
Revenue
584.62B
Revenue Growth
+11.19%
P/S Ratio
7.82
Revenue / Employee
13.60M
Employees
43,000
Market Cap
4.57T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 584.62B | 58.84B | 11.19% |
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 336.53B |
| Cipla | 278.28B |
| Zydus Lifesciences | 271.48B |
| Glenmark Pharmaceuticals | 169.83B |
| Alkem Laboratories | 147.12B |
| Mankind Pharma | 142.78B |
| Divi's Laboratories | 105.60B |
| Ipca Laboratories | 96.46B |
Sun Pharmaceutical Industries News
- 3 days ago - Pharma sector stocks today, July 2: Alembic Pharma falls 1.88%, Glenmark Pharma jumps 0.91%, Sun Pharma gains 0.67% - Business Upturn
- 15 days ago - Sun Pharma to acquire Innovcare Lifesciences for $28.7 million - Reuters
- 15 days ago - Sun Pharmaceutical to acquire Innovcare Lifesciences for Rs 271.2 crore - Business Upturn
- 18 days ago - Brokerage calls today, June 17: Sun Pharma, Polycab, AU SFB, Navin Fluorine, Coforge, PB Fintech in focus - Business Upturn
- 18 days ago - Macquarie reiterates ‘Outperform’ on Sun Pharma, maintains target price of Rs 2,150 - Business Upturn
- 21 days ago - Sun Pharmaceutical Industries reports arrest of independent director Gautam Doshi - Business Upturn
- 24 days ago - Sun Pharmaceutical sets Rs 5 per share final dividend with July 7 record date - Business Upturn
- 27 days ago - Nifty 50 top gainers in morning trades today, June 8: Apollo Hospitals up 1.0%, SBI gains 0.8%, Sun Pharma rises 0.6% - Business Upturn